CD274 and neoplasm: Various factors were reported as predictors for evaluating immunotherapy effectiveness, such as the mutation burden (Snyder et al., 2014), tumor infiltration by cytotoxic T cells (Van Allen et al., 2015), PD-L1 expression (Nishino et al., 2017), and tumor aneuploidy (Davoli et al., 2017).